Skip to main content

Table 2 Correlations between HAMD-17 and SF-36 for both instruments measured at week 0 and measured at week 6 (n = 106)

From: Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine

 

HAMD-17 at week 0

 

HAMD-17 at week 6

SF-36 at week 0

 

SF-36 at week 6

 

 Physical functioning

r = −0.313**

 Physical functioning

r = −0.582**

 Role physical limitations

r = −0.251**

 Role physical limitations

r = −0.433**

 Bodily pain

r = −0.208*

 Bodily pain

r = −0.484**

 General health

r = −0.390**

 General health

r = −0.713**

 Vitality

r = −0.413**

 Vitality

r = −0.699**

 Social functioning

r = −0.211*

 Social functioning

r = −0.609**

 Role emotional limitations

r = −0.198*

 Role emotional limitations

r = −0.493**

 Mental health

r = −0.377**

 Mental health

r = −0.662**

 Physical component summary

r = −0.311**

 Physical component summary

r = −0.569**

 Mental component summary

r = −0.289**

 Mental component summary

r = −0.657**

  1. aHAMD-17 = 17-item Hamilton Depression Rating Scale
  2. bSF-36 = Medical Outcomes Study Short-Form-36
  3. *p < 0.05, **p < 0.01